Amarantus BioScience Holdings, Inc.

Quick facts

Phase 2 pipeline

• Autologous Engineered Skin Substitute · Dermatology
  Autologous Engineered Skin Substitute is a regenerative medicine that uses a patient's own cells to promote skin healing.
• Eltoprazine HCl
  Eltoprazine modulates serotonin receptors in the brain, particularly acting as an agonist at 5-HT1A and 5-HT1B receptors.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Amarantus BioScience Holdings, Inc. portfolio CI brief
• Amarantus BioScience Holdings, Inc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies